Skip to content

Comparison of different administration methods of remifentanil in the intravenous labor analgesia

Comparison of different administration methods of remifentanil in the intravenous labor analgesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050247
Enrollment
Unknown
Registered
2021-08-24
Start date
2021-08-23
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intravenous labor analgesia

Interventions

Control group:Intravenous labor analgesia was not given
Fixed dose group:A fixed dose of remifentanil was given
Individualized dose group:Remifentanil dose varies according to labor process and individualized dose

Sponsors

Chongqing health center for women and children
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Contraindications of intraminal block in puerpera complicated with coagulation function abnormality, platelet abnormality, spinal malformation, puncture site infection, central nervous system disease and so on; 2. The puerpera refused to perform intraspinal labor analgesia due to fear; 3. Failure of intraspinal block or previous lumbar surgery or ineffective intraspinal analgesia; 4. Agree to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. History of opioid allergy, drug dependence, or drug addiction; 2. Complicated obstetric complications, such as pregnancy hypertension placenta previa scar uterus severe hypovolemia and so on; 3. Concomitant respiratory cardiovascular nervous system disease; 4. Abnormal renal and liver function.

Design outcomes

Primary

MeasureTime frame
Sedation score (Ramsay score), VAS pain grade;Fetal heart rate monitoring, Apgar score, Umbilical cord blood gas analysis;Remifentanil concentrations in umbilical cord venous blood and umbilical cord arterial blood;Concentrations of serum cortisol and plasma adrenergic corticotropin in puerpera;

Secondary

MeasureTime frame
Hemodynamic indicators;

Countries

China

Contacts

Public ContactCai Meng

Chongqing health center for women and children

407185194@qq.com+86 17302304865

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026